CClinicalTrials.gg
Status unknownNCT02976025MInD-IUpdated Apr 28, 2021

Remote Supervision for Implementing Collaborative Care for Perinatal Depression

An interventional study of Longitudinal Remote Consultation and Collaborative Care in Perinatal Depression, sponsored by University of Washington. Status unknown at 1 site in United States. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2021-04-28.

Sponsored by University of Washington · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Apr 2021), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This study evaluates the impact of a longitudinal remote consultation (LRC) implementation strategy for collaborative care depression treatment among perinatal women. All participating health centers will receive training in collaborative care. Cluster randomization will be used to assign the addition of LRC to select health centers. Differences in implementation success, clinical outcomes, and costs will be compared after a 12 month implementation period and 13-21 month sustainment period.

Read the detailed description

Depression is a common and serious disorder among pregnant women but few from low income groups receive effective treatment. The highly evidence based collaborative care (CC) model for depression has been shown to work for women in pregnancy but has not been widely implemented in this population. The proposed study targets improving dissemination of the evidence based CC treatment model for pregnant and postpartum women with depression, a common disorder of the perinatal period (pregnancy and the first year following birth). Longitudinal remote consultation (LRC) is an implementation strategy that has been have shown to improve fidelity to evidence-based practices and patient outcomes for mental health innovations. The investigators believe LRC can be used with equal benefit for complex interventions such as CC.

The purpose of this study is to compare two implementation strategies for Collaborative Care depression treatment: 1) standard implementation and 2) standard implementation + Longitudinal Remote Consultation (LRC). This research is being done in order to assess implementation and patient outcomes in sites receiving a standard implementation approach with and without LRC. The results of the proposed study will provide information on the benefits and relative value of ongoing consultation, such as LRC, for implementation of complex interventions like collaborative care.

The proposed study will involve twenty health centers providing prenatal care which are part of the national OCHIN Network or other health center network. All sites will receive a standard implementation approach. After pre-implementation training ten of the sites will be randomly selected to receive LRC. Implementation and clinical outcomes as well as costs will be compared between the study conditions after a 12 month implementation period and a 13-21 month sustainment period. The results of the proposed study will provide critical generalizable knowledge regarding the benefits of ongoing consultation for implementation of complex interventions like collaborative care.

02

Conditions studied

03

In context

Asphyxia Neonatorum

106 studies on the registry are indexed under Asphyxia Neonatorum; 23 are open to participants now.

This study's enrollment of 20 is below the median of 100 across 81 interventional studies indexed under Asphyxia Neonatorum.

Browse Asphyxia Neonatorum studies →

Lead sponsor

University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Patient Participants:

Inclusion Criteria:

  • Patient participants must be perinatal women,
  • Age 18-45,
  • Receiving care at one of the 20 OCHIN or non-OCHIN health centers participating in the study and must have major depression as determined by a score of ≥10 on the PHQ-9 depression screener.

Exclusion Criteria:

  • Age \<18 or >45,
  • Male.

Health Center Participating Sites:

Inclusion Criteria:

  • Use of the shared OCHIN Epic electronic record for perinatal care or use of the secure AIMS CMTS/Caseload Tracker/spreadsheet patient registry for perinatal care and
  • A minimum of 50 prenatal patients annually.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Longitudinal Remote Consultation

    This is the active treatment arm consisting of 10 cluster randomized health centers receiving both training in collaborative care and longitudinal remote consultation (LRC) support.

    Other: Longitudinal Remote Consultation

  • Active comparator
    Collaborative Care

    This comparator arm will consist of 10 cluster randomized health centers who receive training in collaborative care.

    Other: Collaborative Care

Interventions

  • OtherLongitudinal Remote Consultation

    Longitudinal Remote Consultation utilizes video conferencing to efficiently link providers to consultants who provide timely feedback and training in collaborative care. LRC will be provided in addition to standard collaborative care training and support.

    Also known as: LRC

  • OtherCollaborative Care

    Standard collaborative care implementation training and support.

    Also known as: CC

06

What researchers measure

Primary outcomes

  1. Clinical depression outcomes

    Patient Health Questionnaire-9 (PHQ-9); level of depression symptomatology and functional impairment.

    Time frame: 12 months post-initiation of collaborative care

Secondary outcomes

  1. Implementation outcomes

    To assess the degree to which sites in the two conditions complete implementation, the investigators will use the Stages of Implementation Completion tool tailored for collaborative care, SIC-CC.

    Time frame: 12 month post-implementation of collaborative care

Other outcomes

  1. Cost and cost-effectiveness

    For a cost-benefit analysis, the investigators will use of the Cost of Implementing New Strategies (COINS) method to assess costs in the two conditions. This methodology takes advantage of the SIC-CC instrument as a costing template to map the use of resources and associated costs to these to study conditions. Costs associated with implementation in each of these conditions will be carried out for all 20 health centers included in the study.

    Time frame: 12-month post-implementation of collaborative care

07

Study locations

1 site
  • University of Washington
    Seattle, Washington 98195, United States
08

References and documents

Individual participant data

Plan to share: Yes — We intend to share de-identified data once study is complete.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02976025
Lead sponsor
University of Washington
Collaborators
OCHIN, Inc., Oregon Social Learning Center, University of Pennsylvania, Washington University School of Medicine, National Institute of Mental Health (NIMH)
Responsible party
Ian Bennett (Professor, University of Washington) — Principal investigator
First posted
Nov 29, 2016
Start date
Apr 1, 2017
Primary completion
Jul 2021 (estimated)
Completion
Jul 2021 (estimated)
Last update
Apr 28, 2021

Study contacts

Ian Bennett
principal investigator · University of Washington

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion